Texsan marks 1,200-procedure milestone reducing stroke risk for patients

Methodist Hospital Texsan announced today that its Cardiac Electrophysiology (EP) team has successfully performed more than 1,200 left atrial appendage closure (LAAC) implant procedures for eligible patients living with atrial fibrillation (AFib) — a milestone that reflects Texsan's sustained focus on preventing strokes and improving quality of life for patients across South Texas. 

LAAC is an FDA approved option for certain AFib patients who are not good candidates for long term anticoagulation (blood thinner) therapy. By sealing the left atrial appendage, a small pouch where clots commonly form in AFib, LAAC reduces the risk that a clot will travel to the brain and cause stroke. 

"This is more than a procedural milestone — it's about preventing strokes before they happen, safeguarding lives and dignity for our patients," said Dr. Javiar Roman-Gonzales, who specializes in clinical cardiac electrophysiology at Texsan.  " Our EP team's achievement highlights the commitment at Texsan Hospital to provide lifesaving, cutting edge technologies to our South Texas community."  

Conversations with the clinical team underscore what the numbers alone cannot capture. For appropriate patients, LAAC can help them discontinue long term blood thinners under the guidance of a physician. That change can be meaningful for many older adults and others at higher risk of falls or bleeding. Patients and families frequently cite fewer bruises from minor bumps, less worry about nosebleeds or cuts taking longer to stop, and greater flexibility when other procedures are needed, as blood thinners must be paused. 

“Each implant is not just about a device, but about giving someone additional years of health and independence,” said Charisma MacIndoe, MD, chief medical officer at Methodist Hospital Texsan. “We frequently care for active patients who worry about the downsides of long term blood thinners. When LAAC is appropriate, it can make day to day life feel safer." 

Methodist Hospital Texsan’s high volume LAAC program is supported by a multidisciplinary team, including EP physicians, anesthesiologists, imaging specialists, nursing staff, and patient navigation personnel, who coordinate pre-procedure evaluation, education, and post procedure follow up. The program's growth to over 1,200 procedures reflect consistent adoption of evidence based practices and a culture of collaboration centered on safety and outcomes. 

Patients with atrial fibrillation who are concerned about stroke risk or who cannot tolerate long term anticoagulant therapy should speak with their cardiologist or contact Methodist Hospital Texsan’s EP team to discuss whether LAAC may be an appropriate option. Early evaluation and treatment can make a difference.